VERTEPORFIN THERAPY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGERELATED MACULAR DEGENERATION: FOUR-YEAR RESULTS OF AN OPEN-LABEL EXTENSION OF 2 RANDOMIZED CLINICAL TRIALS: TAP REPORT NO. 7.

BRESSLER, N.M., BRESSLER, S.B., HAYNES, L.A., HAO, Y., KAISER, P.K., & MILLER, J.W.. (2005). VERTEPORFIN THERAPY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGERELATED MACULAR DEGENERATION: FOUR-YEAR RESULTS OF AN OPEN-LABEL EXTENSION OF 2 RANDOMIZED CLINICAL TRIALS: TAP REPORT NO. 7.. ARCHIVES OF OPHTHALMOLOGY, 123(9), 1283-1285. SID. https://sid.ir/paper/566118/en

BRESSLER N.M., BRESSLER S.B., HAYNES L.A., HAO Y., KAISER P.K., MILLER J.W.. VERTEPORFIN THERAPY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGERELATED MACULAR DEGENERATION: FOUR-YEAR RESULTS OF AN OPEN-LABEL EXTENSION OF 2 RANDOMIZED CLINICAL TRIALS: TAP REPORT NO. 7.. ARCHIVES OF OPHTHALMOLOGY[Internet]. 2005;123(9):1283-1285. Available from: https://sid.ir/paper/566118/en

N.M. BRESSLER, S.B. BRESSLER, L.A. HAYNES, Y. HAO, P.K. KAISER, and J.W. MILLER, “VERTEPORFIN THERAPY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGERELATED MACULAR DEGENERATION: FOUR-YEAR RESULTS OF AN OPEN-LABEL EXTENSION OF 2 RANDOMIZED CLINICAL TRIALS: TAP REPORT NO. 7.,” ARCHIVES OF OPHTHALMOLOGY, vol. 123, no. 9, pp. 1283–1285, 2005, [Online]. Available: https://sid.ir/paper/566118/en